As the activation of bitter taste receptors such as TAS2R50 counteracts inflammatory stimuli [16], it should be investigated, whether anti-cancer effects triggered by TAS2Rs activation and higher expression of TAS2Rs interfere with tumour promoting inflammation processes, resulting in further anti-cancer effects. This evidence concerns the gene TAS2R50 and cancer.